SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-18-072553
Filing Date
2018-12-12
Accepted
2018-12-12 16:16:51
Documents
5
Period of Report
2018-10-04
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A a18-40859_18ka.htm 8-K/A 34939
2 EX-23 a18-40859_1ex23.htm EX-23 9647
3 EX-99.2 a18-40859_1ex99d2.htm EX-99.2 556183
4 EX-99.3 a18-40859_1ex99d3.htm EX-99.3 579873
5 EX-99.4 a18-40859_1ex99d4.htm EX-99.4 835646
  Complete submission text file 0001104659-18-072553.txt   2017349
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33137 | Film No.: 181231062
SIC: 2834 Pharmaceutical Preparations